Acura Pharmaceuticals Inc (NASDAQ:ACUR)

0.987
Delayed Data
As of 3:59pm ET
 +0.047 / +5.00%
Today’s Change
0.41
Today|||52-Week Range
1.35
+119.33%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +102.63% increase from the last price of 0.99.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$2.9M
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -166.67%
 
 
 
 
 
 
Growthannually 81.48%
 
 
 
 
 
 

Sales

Growthquarterly -45.87%
 
 
 
 
 
 
Growthannually 1,790.81%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account